Adial Pharmaceuticals, Inc (ADIL)
NASDAQ · Manufacturing · Pharmaceutical preparations
$4.22−$0.2200 (−4.95%) on the dayAs of the close; data may be delayed.
ADIL price, last 12 months
Key stats
- Previous close
- $4.44
- Open
- $4.40
- Day range
- $4.12 – $4.56
- 52-week range
- $1.31 – $10.75
- Volume
- 33.2K
- Avg volume (20 days)
- 50.8K
- Market cap
- $12.4M
Performance
1W−13.2%
1M−29.0%
3M+64.8%
6M+145.4%
YTD−23.3%
1Y−51.5%
vs S&P 500, 1Y−68.2 pts
Technicals and fundamentals
About Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $12.4M